Literature DB >> 19443455

Interactions between apoptotic signal transduction and capacitation in human spermatozoa.

S Grunewald1, C Kriegel, T Baumann, H-J Glander, U Paasch.   

Abstract

BACKGROUND: Capacitation of sperm is a prerequisite for successful fertilization, determined by hyperactivated motility, increased tyrosine phosphorylation (TyrP) and membrane changes. However, the exact molecular mechanism is not fully clarified. The calpain-calmodulin-system is essential for membrane fusion during capacitation. Recently, interactions with caspase (CP) activation, a main feature of apoptotic cells, were postulated. The objective of our study was to examine interactions between apoptosis signalling and the calpain-calmodulin-system during capacitation.
METHODS: Semen samples from 20 healthy donors were incubated in human tubal fluid at 37 degrees C, 5% CO(2) for 3 h without additives (control), with 3% BSA (capacitation), 10 microM calpain-inhibitor III, 20 microM CP-1 inhibitor or 20 microM calmodulin-antagonist. Capacitation was monitored by computer assisted sperm motion analyzer, chlortetracycline (CTC)-assay and western blot (TyrP). Activation of caspases and integrity of transmembrane mitochondrial potential (TMP) were evaluated by flow cytometry.
RESULTS: Capacitation, as measured by CTC assay, increased TyrP levels and hyperactivation, resulted in inactivation of CP-9, CP-3 and improved integrity of the TMP. Inhibition of calpain and CP-1 during capacitation reduced the capacitation-related parameters, but did not lead to apoptosis. Inhibition of calmodulin resulted in blocking of capacitation and stimulation of apoptosis.
CONCLUSION: Interaction of the capacitation and apoptosis signalling systems seems to enable the capacitation process by prevention of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443455     DOI: 10.1093/humrep/dep178

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Apoptotic sperm biomarkers and their correlation with conventional sperm parameters and male fertility potential.

Authors:  Branko Zorn; Barbara Golob; Alojz Ihan; Andreja Kopitar; Mojca Kolbezen
Journal:  J Assist Reprod Genet       Date:  2012-02-24       Impact factor: 3.412

2.  Evaluation of ubiquitin and annexin V in sperm population selected based on density gradient centrifugation and zeta potential (DGC-Zeta).

Authors:  M Zarei-Kheirabadi; E Shayegan Nia; M Tavalaee; M R Deemeh; M Arabi; M Forouzanfar; Gh R Javadi; M H Nasr-Esfahani
Journal:  J Assist Reprod Genet       Date:  2011-12-20       Impact factor: 3.412

3.  Ophiobolin A from Bipolaris oryzae perturbs motility and membrane integrities of porcine sperm and induces cell death on mammalian somatic cell lines.

Authors:  Ottó Bencsik; Tamás Papp; Máté Berta; Annamária Zana; Péter Forgó; György Dombi; Maria A Andersson; Mirja Salkinoja-Salonen; Csaba Vágvölgyi; András Szekeres
Journal:  Toxins (Basel)       Date:  2014-09-23       Impact factor: 4.546

Review 4.  The Biological Activities of Sesterterpenoid-Type Ophiobolins.

Authors:  Wei Tian; Zixin Deng; Kui Hong
Journal:  Mar Drugs       Date:  2017-07-18       Impact factor: 5.118

5.  Induction of ultra-morphological features of apoptosis in mature and immature sperm.

Authors:  Sonja Grunewald; Guenther Fitzl; Christopher Springsguth
Journal:  Asian J Androl       Date:  2017 Sep-Oct       Impact factor: 3.285

6.  Sperm midpiece apoptotic markers: impact on fertilizing potential in in vitro fertilization and intracytoplasmic sperm injection.

Authors:  Joanna Talarczyk-Desole; Małgorzata Kotwicka; Magdalena Jendraszak; Leszek Pawelczyk; Marek Murawski; Piotr Jędrzejczak
Journal:  Hum Cell       Date:  2016-01-20       Impact factor: 4.174

7.  17β-estradiol modifies human spermatozoa mitochondrial function in vitro.

Authors:  Malgorzata Kotwicka; Izabela Skibinska; Magdalena Jendraszak; Piotr Jedrzejczak
Journal:  Reprod Biol Endocrinol       Date:  2016-08-26       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.